A detailed history of Voya Investment Management LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 15,603 shares of PBYI stock, worth $47,433. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,603
Previous 15,603 -0.0%
Holding current value
$47,433
Previous $50,000 22.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.92 - $5.83 $45,560 - $90,965
15,603 New
15,603 $50,000
Q2 2022

Aug 15, 2022

SELL
$1.64 - $3.3 $19,335 - $38,907
-11,790 Reduced 11.33%
92,237 $263,000
Q1 2022

May 16, 2022

BUY
$2.13 - $3.24 $36 - $55
17 Added 0.02%
104,027 $300,000
Q4 2021

Feb 14, 2022

BUY
$2.85 - $6.58 $192,298 - $443,972
67,473 Added 184.67%
104,010 $317,000
Q3 2021

Nov 15, 2021

BUY
$6.63 - $9.39 $5,774 - $8,178
871 Added 2.44%
36,537 $256,000
Q2 2021

Aug 16, 2021

BUY
$8.98 - $11.6 $60,992 - $78,787
6,792 Added 23.52%
35,666 $328,000
Q1 2021

May 17, 2021

BUY
$9.38 - $13.63 $33,908 - $49,272
3,615 Added 14.31%
28,874 $281,000
Q4 2020

Feb 16, 2021

BUY
$7.78 - $12.13 $35,305 - $55,045
4,538 Added 21.9%
25,259 $259,000
Q3 2020

Nov 16, 2020

BUY
$9.5 - $11.14 $17,480 - $20,497
1,840 Added 9.75%
20,721 $209,000
Q2 2020

Aug 14, 2020

BUY
$7.01 - $13.24 $21,808 - $41,189
3,111 Added 19.73%
18,881 $197,000
Q4 2019

Feb 14, 2020

BUY
$6.5 - $10.73 $18,603 - $30,709
2,862 Added 22.17%
15,770 $138,000
Q2 2019

Aug 14, 2019

SELL
$12.3 - $35.76 $2.61 Million - $7.59 Million
-212,323 Reduced 94.27%
12,908 $164,000
Q1 2019

May 15, 2019

SELL
$20.77 - $42.37 $10.6 Million - $21.7 Million
-512,552 Reduced 69.47%
225,231 $8.74 Million
Q4 2018

Feb 14, 2019

BUY
$20.07 - $46.7 $6.49 Million - $15.1 Million
323,122 Added 77.92%
737,783 $15 Million
Q3 2018

Nov 14, 2018

BUY
$41.2 - $59.85 $7.55 Million - $11 Million
183,166 Added 79.12%
414,661 $19 Million
Q2 2018

Aug 14, 2018

SELL
$48.3 - $68.25 $6.58 Million - $9.3 Million
-136,286 Reduced 37.06%
231,495 $13.7 Million
Q1 2018

May 15, 2018

BUY
$59.7 - $99.25 $6.85 Million - $11.4 Million
114,774 Added 45.36%
367,781 $25 Million
Q4 2017

Feb 14, 2018

SELL
$93.85 - $132.45 $4.45 Million - $6.28 Million
-47,417 Reduced 15.78%
253,007 $25 Million
Q3 2017

Nov 14, 2017

BUY
$72.0 - $119.75 $21.6 Million - $36 Million
300,424
300,424 $36 Million

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $138M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.